EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access

Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism

André Luiz Santos Pessoa, Thiago Gonçalves Guimarães iD, Diego de Castro Dos Santos iD, Renata Montes Garcia Barbosa, Ellen Mourao Soares Lopes, Claudio M de Gusmao iD, Pedro Lucas Grangeiro Sá Barreto Lima iD, Matheus Augusto Araújo Castro iD, Fernando Kok, Paulo Ribeiro Nobrega

Movement Disorders Clinical Practice · 2026-11 · 13 (11) · 3043-3050

DOI: 10.1002/mdc3.70731 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 07.07.2026. Verfasst von André Luiz Santos Pessoa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Infantil Albert Sabin, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Parkinsonian Disorders, HSP40 Heat-Shock Proteins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biallelic variants in DNAJC6 cause PARK‐ DNAJC6 (historically referred to as PARK19), a rare autosomal recessive juvenile‐onset dystonia‐parkinsonism syndrome. Neurodevelopmental delay or regression, epilepsy, movement disorders, and psychiatric symptoms are also present. Progression is fast with frequent bulbar, gastrointestinal involvement and early loss of ambulation. Cases We report two siblings (17 and 14 years) harboring a novel homozygous nonsense variant in DNAJC6 , p.Cys325*, not previously described in the medical literature and absent from population databases. The variant is predicted to truncate the protein, supporting a loss‐of‐function mechanism consistent with the gene's disease biology. Both patients exhibited developmental regression, parkinsonism with dystonia, cognitive decline, dysphagia, and marked sialorrhea, with severe, accelerated functional deterioration. Levodopa produced only mild benefit; in the older sibling, dose escalation provoked an adverse reaction with sustained upgaze/ophthalmoparesis, opisthotonus, and hypertension. Literature review We found 23 previously reported DNAJC6 patients, most with early‐onset parkinsonism with variable levodopa responsiveness, frequent developmental and psychiatric comorbidity, and prominent bulbar features.

Conclusions

The novel DNAJC6 p.Cys325* variant is associated with severe, early‐onset parkinsonism and developmental regression. DNAJC6 should be considered in children and adolescents presenting with parkinsonism plus neurodevelopmental decline, particularly when levodopa benefit is modest, and dose‐related adverse motor crises occur.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinsonian DisordersHSP40 Heat-Shock ProteinsHumansAdolescentDisease ProgressionMaleHomozygoteFemale

Stichwörter der Autor:innen

DNAJC6PARK19auxilindystoniaearly‐onset parkinsonism

Substanzen

DNAJC6 protein, humanHSP40 Heat-Shock Proteins

Autor:innen und Institutionen

  • Hospital Infantil Albert Sabin, Fortaleza, Brazil.
  • Department of Neurology, Movement Disorders Center, University of Sao Paulo, Sao Paulo, Brazil.
  • Department of Neurology, Neurogenetics Center, University of São Paulo, Sao Paulo, Brazil.
  • Department of Neurology, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Neurology, Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Brazil.

ORCID-Profile: Thiago Gonçalves Guimarães, Diego de Castro Dos Santos, Claudio M de Gusmao, Pedro Lucas Grangeiro Sá Barreto Lima, Matheus Augusto Araújo Castro

Zitieren

APA

Pessoa, A. L. S., Guimarães, T. G., de Castro Dos Santos, D., Barbosa, R. M. G., Lopes, E. M. S., de Gusmao, C. M., Lima, P. L. G. S. B., Castro, M. A. A., Kok, F., & Nobrega, P. R. (2026). Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism. Movement Disorders Clinical Practice, 13(11), 3043-3050. https://doi.org/10.1002/mdc3.70731

Vancouver

Pessoa ALS, Guimarães TG, de Castro Dos Santos D, Barbosa RMG, Lopes EMS, de Gusmao CM, et al. Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism. Movement Disorders Clinical Practice. 2026;13(11):3043-3050. doi:10.1002/mdc3.70731

BibTeX
@article{Pessoa2026,
  author = {Pessoa, André Luiz Santos and Guimarães, Thiago Gonçalves and de Castro Dos Santos, Diego and Barbosa, Renata Montes Garcia and Lopes, Ellen Mourao Soares and de Gusmao, Claudio M and Lima, Pedro Lucas Grangeiro Sá Barreto and Castro, Matheus Augusto Araújo and Kok, Fernando and Nobrega, Paulo Ribeiro},
  title = {Novel Homozygous Pathogenic Variant in DNAJC6 Causes Rapid Progressive Parkinsonism},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {3043--3050},
  doi = {10.1002/mdc3.70731}
}
Kostenlos starten →